LendingTree, Inc.TREE reported fourth-quarter 2025 adjusted net loss per share of 39 cents against the Zacks Consensus Estimate of earnings of 90 cents and the year-ago adjusted net income of $1.16

B&G Foods, Inc. BGS posted fourth-quarter 2025 results, wherein the bottom line came in line with the Zacks Consensus Estimate, but declined year over year. The top line was pressured by recent

Sea Limited SE reported adjusted earnings of 80 cents per share in the fourth quarter of 2025, which increased 29% from the year-ago quarter but missed the Zacks Consensus Estimate by

Investors in South Plains Financial, Inc. SPFI need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $22.50 Put had some of the

Esperion Therapeutics ESPR announced that it has entered into a definitive agreement to acquire Nevada-based, privately held, commercial-stage biopharmaceutical company, Corstasis Therapeutics, for

Shares of Theravance Biopharma TBPH plunged 26% after the company announced the failure of the late-stage CYPRESS study evaluating ampreloxetine, an investigational, once-daily norepinephrine

GitLab GTLB reported fourth-quarter fiscal 2026 non-GAAP earnings of 30 cents per share, beating the Zacks Consensus Estimate by 32.57%. The company reported earnings of 33 cents per share in the

Investors in Kennametal Inc. KMT need to pay close attention to the stock based on moves in the options market lately. That is because the April 17, 2026 $15.00 Put had some of the highest implied

USA Rare Earth, Inc. USAR is progressing with development of its Stillwater magnet manufacturing facility in Oklahoma as it moves closer to commercial production. The site will manufacture Neodymium